Skip to main content
Goodwill Pharma Plc logo

Goodwill Pharma Plc — Investor Relations & Filings

Ticker · GWPH ISIN · HU0000199575 BUD Manufacturing
Open in API
Filings indexed 35 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country HU Hungary
Listing BUD GWPH

About Goodwill Pharma Plc

www.goodwillpharma.com

Goodwill Pharma Plc is a fully integrated pharmaceutical service provider engaged in the development, manufacturing, and distribution of therapeutic products. Its portfolio comprises medicines, food supplements, and medical devices. The company operates as a Contract Development and Manufacturing Organization (CDMO), offering comprehensive solutions that span the entire pharmaceutical lifecycle, from research and development to large-scale commercial manufacturing. Core services include product development, regulatory affairs, pharmacovigilance, production, logistics, and marketing support. Goodwill Pharma collaborates with academic institutions on research projects to foster innovation. The company primarily serves markets in Central and Eastern Europe, with an expanding international presence through various partnerships.

Recent filings

Filing Released Lang Actions
Tájékoztatás alaptőkéről és szavazati jogokról
Regulatory Filings
2026-04-30 Hungarian
Tájékoztatás vezetői feladatot ellátó személy ügyleteiről
Director's Dealing Classification · 1% confidence The document is a notification of share transactions by a company director (Dr. Jójárt Ferenc), detailing the dates, quantities, and prices of his purchases of the company’s shares. This fits the definition of a Director's Dealing report (insider share transaction disclosure).
2026-04-28 Hungarian
Közgyűlési előterjesztések
AGM Information Classification · 1% confidence The document is titled “Előterjesztések és határozati javaslatok a GOODWILL PHARMA Nyrt. éves rendes közgyűlésére,” listing agenda items, proposals and resolutions for the upcoming Annual General Meeting. It contains the materials to be presented and voted on at the AGM. This clearly falls under “AGM Information”.
2026-04-07 Hungarian
Közgyűlési előterjesztések
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a sample proxy authorization form (“meghatalmazás”) enabling shareholders (natural or legal persons) to appoint proxies for the April 29, 2026 general meeting. This is part of materials sent to shareholders to request votes. It is therefore a Proxy Solicitation & Information Statement (PSI).
2026-04-07 Hungarian
Közgyűlési előterjesztések
Proxy Solicitation & Information Statement Classification · 1% confidence The document is an annex (“8. számú melléklet”) detailing the company’s share capital structure and voting rights as of the general meeting convocation date (2026-03-27). This is clearly part of the information packet sent to shareholders ahead of a general meeting to inform and solicit their votes, not a standalone results declaration or a full annual/interim report. Therefore it fits the definition of a Proxy Solicitation & Information Statement (PSI).
2026-04-07 Hungarian
Közgyűlési előterjesztések
Regulatory Filings Classification · 0% confidence The provided text is a personal resume/CV in Hungarian, detailing an individual’s professional background, skills, education, and contact information. It does not correspond to any corporate financial or regulatory filing categories such as earnings releases, annual reports, management changes, or investor presentations. Therefore, it defaults to the fallback category for miscellaneous regulatory announcements.
2026-04-07 Hungarian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.